MAHON PAUL A (CIK 1231589) reported 330 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-18). Recent activity: Sell UTHR (320 shares), Sell UTHR (1,579 shares), Sell UTHR (2,873 shares), Sell UTHR (1,400 shares), Sell UTHR (843 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-18 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Sell | 320 | $160,506 |
| 2026-09-18 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Sell | 1,579 | $783,132 |
| 2026-09-18 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Sell | 2,873 | $1.4M |
| 2026-09-18 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Sell | 1,400 | $696,561 |
| 2026-09-18 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Sell | 843 | $420,435 |
| 2026-09-18 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Sell | 1,160 | $579,712 |
| 2026-09-18 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Sell | 125 | $62,600 |
| 2026-09-18 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Buy | 8,300 | $1.2M |
| 2026-09-03 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Sell | 1,048 | $505,049 |
| 2026-09-03 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Sell | 1,545 | $739,954 |
| 2026-09-03 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Sell | 936 | $448,959 |
| 2026-09-03 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Sell | 2,360 | $1.1M |
| 2026-09-03 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Buy | 8,300 | $1.2M |
| 2026-09-03 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Sell | 160 | $77,226 |
| 2026-09-03 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Sell | 200 | $96,770 |
| 2026-09-03 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Sell | 954 | $462,807 |
| 2026-09-03 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Sell | 598 | $290,908 |
| 2026-09-03 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Sell | 169 | $82,364 |
| 2026-09-03 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Sell | 10 | $4,883 |
| 2026-09-03 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Sell | 320 | $157,083 |
| 2026-08-21 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Buy | 2,690 | $392,821 |
| 2026-08-21 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Buy | 5,610 | $819,228 |
| 2026-08-21 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Sell | 2,690 | $1.4M |
| 2026-08-21 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Sell | 502 | $261,057 |
| 2026-08-21 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Sell | 1,819 | $947,773 |
来源：SEC Form 4 申报文件 · 截至 2026-09-18